J. Goldman & CO LP Spectrum Pharmaceuticals Inc Transaction History

J. Goldman & CO LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$9.08 - $11.84 $2.43 Million - $3.17 Million	-267,801 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$6.39 - $16.99 $904,983 - $2.41 Million	-141,625 Reduced 34.59%	267,801 $2.34 Million
Q3 2018 Nov 14, 2018	SELL	$16.52 - $24.82 $4.71 Million - $7.07 Million	-284,912 Reduced 41.03%	409,426 $6.88 Million
Q2 2018 Aug 14, 2018	BUY	$14.31 - $21.75 $3.18 Million - $4.83 Million	221,902 Added 46.97%	694,338 $14.6 Million
Q1 2018 May 15, 2018	BUY	$16.09 - $23.07 $3.31 Million - $4.75 Million	205,957 Added 77.29%	472,436 $7.6 Million
Q4 2017 Feb 14, 2018	BUY	$13.36 - $20.73 $1.09 Million - $1.69 Million	81,504 Added 44.06%	266,479 $5.05 Million
Q3 2017 Nov 14, 2017	BUY	$8.75 - $14.07 $1.62 Million - $2.6 Million	184,975	184,975 $2.6 Million

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.